New measures put pressure on drug makers, importers and distributors
South Korea’s latest moves to make drugs more affordable are slowing down the growth of the pharma market in the country and maybe hurting sales of new and innovative drugs.
BMI Research predicts South Korean pharmaceutical will grow at 2.4% for the next 10 years, 1% less than expected. Elise Mak wrote about the changes in BioWorld (paywall) on May 4.
5 December 2016
Not so much a shift in policy but a growing trend
There has been so much discussion of the United States pivot to Asia that few people have stopped to consider the implications or the success of China’s own pivot to America.
China already wields enormous influence in Asia through its size and its adroitness at negotiating, buying or bullying its way to goodwill among its partners – much like every other player on the geopolitical landscape. It has or is part of free trade agreements that include just about every country in the region.
22 November 2016
The “man on the street” will be the biggest loser
All the talk that has erupted in the past couple of weeks about possible trade wars between the United States and China has been interesting in the way that a soap opera is interesting: lots of drama with little link to reality.
Sure, it is easy to use China as a scapegoat. A place that is conveniently far away and too big to understand. It is easy to say “look, it is China’s fault and we will put the hurt on them and things will be lovely all around”. If only that were true.
15 November 2016
The economics of misplaced anger
Fast growing Asian countries have “eliminated” poverty at an astonishing speed, bringing people out of extreme poverty into mere gut-reaching poverty.
At first blush, the numbers are suggesting of a hopeful future. In 1990, about a third of the people in the world lived on less than US$1.90 a day. By 2013, it was just 10.7%. In actual numbers, that is 1.85 billion in 1990 compared to 767 million in 2013. A second glance puts in perspective the anger of many people in the world, and not in a good way.
11 April 2016
Why the switch from coca to cacao is hard to do
There are few issues with just two sides or a clear right and wrong.
This is a recurrent theme for us and one that Sergio Held makes quite clear in a recent story for Ozy that considers the difficulty that Colombia is facing in cutting down on drug production.
31 March 2016
Looking to the future
This year’s BOAO Forum for Asia (BFA) has a theme of Asia’s New Future: New Dynamics, New Vision.
This time, the 17th annual gathering of leaders and industry professionals in Asia covers areas such as inclusive finance, disruptions of traditional business and economic models, new banking practices, regional cooperation and growing links through reforms and initiatives.
8 April 2015
Largest ASEAN economy claims economic prowess but foreign investors remain unconvinced
When Indonesia’s Investment Coordinating Board (BKPM) rejected some 6,541 foreign investment permits last month, it underscored a problem Indonesia has been facing for a couple of years. Investors are looking at the country. They are scouting deals. They are searching for opportunities. They are not always investing, though.
Last year Indonesia attracted around US$24 billion in foreign investment but that is about a quarter of the total investment that China attracts and less than half of what Brazil receives, reports MNI’s Asia Insight. For the country to maintain levels of economic growth of close to 6% per year, it will need a lot more investment.
7 April 2015
Environment, productivity and work hours are all big issues
Asia is home to some of the largest urban centres in the world.
Jakarta, in Indonesia, is home to some 25 million people. Manila is huge. Tokyo and Seoul are both large. Smaller Hong Kong and Singapore are large by any standard. High urbanisation rates are making these cities even larger, but not necessarily more sustainable.
As Cornelia Zou reports in China Daily Asia Pacific last week the challenges are quite significant, but so are the opportunities for Asian cities to start taking issues of sustainability seriously and make significant leapfrogs in terms of the environments, quality of life, education, even work hours and governance.
30 January 2015
Lower subsidies cut government costs and could help build infrastructure
Cheap oil has helped Indonesia eliminate punishing subsidies and while the move is likely to bump inflation up, it will also free up a about US$21 billion that the government can now spend on infrastructure or social programs.
All this is good news for the economy, which is still making a comeback from a mini-crisis in 2013. Growth this year is expected to be in the 5.5% range, around the same level as Malaysia. Inflation could average out to 4%.
Speaking during the Asian Financial Forum in Hong Kong, the deputy governor of Bank Indonesia Perry Warjiyo said the country’s central bank is more likely than not to keep its policy rate steady at 7.75%. As this piece in Asia Insight, a Market News International publication, points out things are looking good for the largest economy in Southeast Asia.
3 December 2014
A long-awaited set of guidelines for a billion-dollar market.
After years of waiting, Chinese biosimilar makers will soon have a set of guidelines to follow.
This post on Thomson Reuters Life Sciences Connect news blog (HERE) outlines the industry’s reaction to the draft biosimilar guidelines.
The global biologics market is experiencing a golden age over the current decade. As drug development progresses, it’s time for biopharmaceutical companies to start reaping its rewards. The market is expected to grow more than 80 percent from $138 billion in 2010 to $253 billion by 2020, according to Sandoz international GmbH. And $2 billion of this will be coming from biosimilar products.